Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Duration of Eculizumab therapy for a clinical...
Conference

Duration of Eculizumab therapy for a clinical response in atypical hemolytic uremic syndrome.

Authors

Mian H; Chan A; Lau K; Chan H

Name of conference

International Society of Hemostasis and Thrombosis.

Conference place

Toronto